Manufacture of pharmaceutical preparations
AGILERA PHARMA AS
Revenue 2024
NOK 357.6m
Operating profit
NOK −29.0m
Equity
NOK 15.0m
Incorporated
2021
Employees
137
Share capital
NOK 4.5m
Key figures · 2024
Current ratio
1.13
Equity ratio
10.1%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -8.1% | |
| Net margin (%%) | -9.7% | |
| Return on assets (%%) | -19.4% | |
| Likviditet | ||
| Current ratio | 1.13 | |
| Working capital | 11.3m | |
| Soliditet | ||
| Equity ratio (%%) | 10.1% | |
| Debt-to-equity ratio | 8.93 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.